戻る
Biocartis Secures FDA Premarket Approval for Idylla™ CDx MSI Test
戻る
株式ニュース
テーマ
Biocartis Secures FDA Premarket Approval for Idylla™ CDx MSI Test
がん研究
Biocartis Secures FDA Premarket Approval for Idylla™ CDx MSI Test
Edgen Stock
·
Sep 19 2025, 01:36
共有先
共有先
リンクをコピー
ソース：
[1] Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
[2] Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
[3] FDA approves Biocartis Idylla Cdx MSI colorectal cancer test - BioWorld
Edgen Stock·Sep 19 2025, 01:36Edgen Stock·Sep 19 2025, 01:36
Edgen Stock·Sep 19 2025, 01:36